Paper Review Records
All Paper Review Records
20 valid samples · Newest publication first
Review days = acceptance date − received date. PDF, DOI, and publisher-page sources are retained.
METTL3 Regulates ATIC Expression via m6A Methylation: Implications for Methotrexate Action in Rheumatoid Arthritis
Baojing Zhao; Yuqian Miao; Xiudi Wu; Dongmei Xiao; Hua Huang; Tinghui Wang; Huyan WangShow moreShow less
1. Department of Rheumatology and Immunology, The First Affiliated Hospital of Ningbo University, 315010 Ningbo, Zhejiang, ChinaShow moreShow less
Prophylactic Short-Chain Fatty Acid Supplementation Modulates Circulating Immunometabolic Biomarkers and Reduces Organ-Injury Markers in CLP-Induced Sepsis
Pınar Ellergezen; Yusuf Berkcan Yanar; Mustafa Sertaç Yılmaz; Sinan ÇavunShow moreShow less
1. Department of Medical Pharmacology, Faculty of Medicine, Bursa Uludag University, 16059 Bursa, TurkiyeShow moreShow less
CC16 Ameliorates Inflammatory Responses and Acute Lung Injury in Mice by Modulating NF-κB/MAPK Signaling
Zhou Wang; Qiqi Xie; An WangShow moreShow less
1. Department of Emergency, The People’s Hospital of Pingyang, 325400 Wenzhou, Zhejiang, China; 2. Department of Intensive Care Unit, Pingyang Hospital of Traditional Chinese Medicine, 325400 Wenzhou, Zhejiang, ChinaShow moreShow less
Aurora Kinases Have the Potential to Serve as an Effective Therapeutic Strategy in the Treatment of Various Types of Cancer
Chao Shen; Meng Du; Hao Chi; Shuangxing Wu; Fankai XiaoShow moreShow less
1. Teaching and Research Office of Clinical Laboratory Science, Huai’an Clinical Medical College of Jiangsu University, 223200 Huai’an, Jiangsu, China; 2. Department of Laboratory Medicine, Huai’an Hospital of Huai’an City, 223200 Huai’an, Jiangsu, China; 3. Department of Oncology, The First Affiliated Hospital of Zhengzhou University, 450052 Zhengzhou, Henan, ChinaShow moreShow less
JAK/STAT3/MMP9 Pathway Inhibition by Epigallocatechin-3-Gallate Alleviates Experimental Abdominal Aortic Aneurysm
Jianhua Nian; Jingang Han; Zhi Yu; Xiaoyan ZhuShow moreShow less
1. Department of Vascular Surgery, The Second Affiliated Hospital of Zhejiang Chinese Medical University, 310005 Hangzhou, Zhejiang, China; 2. Department of General Surgery, Haining Central Hospital, 314408 Haining, Zhejiang, ChinaShow moreShow less
Longitudinal Analysis of Urine Metabolomics in Preterm Infants Based on UHPLC-MS/MS Technique
Sha Hong; Tianyi Liu; Xiyan Mu; Fujie Wen; Qian Shen; Yihui Zhai; Huiru Tang; Hong XuShow moreShow less
1. Department of Nephrology, Children’s Hospital of Fudan University, 201102 Shanghai, China; 2. State Key Laboratory of Genetic Engineering, Ministry of Education Key Laboratory of Contemporary Anthropology, School of Life Sciences, Fudan University, 200438 Shanghai, China; 3. Pediatric Internal Medicine Department I, First People’s Hospital of Kashi, 844000 Kashi, Xinjiang, ChinaShow moreShow less
FAQ
How long does Discovery Medicine take to review a manuscript?
As of 2026-11-19, CrushSCI has 20 complete review records for Discovery Medicine. The fastest paper went from submission to acceptance in 32 days (Knockdown of IGFBP7 Alleviates High Glucose-Triggered Vascular Endothelial Injury and Is Associated With the Upregulation of AURKA in HUVECs, received 2026-06-08, accepted 2026-07-10); the slowest took 139 days. The average is 68.6 days and the median is 54 days.
Expert Matching · Case Demo
Turn Your Submission Goalsinto a Verifiable Journal Plan
Share your field, deadline, and author profile. CrushSCI uses real review records to suggest a title direction, shortlist journals, and estimate timelines.
